Skip to main content
Top
Published in: Current Infectious Disease Reports 4/2011

01-08-2011

Vascular Access Infections: Epidemiology, Diagnosis, and Management

Author: Jacob A. Akoh

Published in: Current Infectious Disease Reports | Issue 4/2011

Login to get access

Abstract

Infection is the most challenging and life-threatening complication of vascular access and causes significant morbidity, loss of access, and mortality. The aims of this review are to determine the magnitude of the infection problem, identify possible factors, and provide an update on the management of vascular access infections. Infections account for approximately 15% to 36% of all deaths in dialysis patients (the second leading cause after cardiovascular events) and for about 20% of admissions. Several studies demonstrate a hierarchy of infection risk from temporary catheter, tunnelled cuffed catheter, arteriovenous grafts, to arteriovenous fistula in decreasing order. Suspicion of infection must be followed by appropriate blood cultures, including possible simultaneous sampling from a peripheral vein and the access. The best way to treat vascular access infection is prevention, bearing in mind the idea “fistula first” and “lines last”, with the appropriate use of arteriovenous grafts and newer devices sandwiched in between.
Literature
1.
go back to reference Lok CE. Firstula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2:1043–53.PubMedCrossRef Lok CE. Firstula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2:1043–53.PubMedCrossRef
2.
go back to reference Lemaire X, Morena M, Leray-Moragués H, et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for haemodialysis. Blood Purif. 2009;28:21–8.PubMedCrossRef Lemaire X, Morena M, Leray-Moragués H, et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for haemodialysis. Blood Purif. 2009;28:21–8.PubMedCrossRef
3.
go back to reference • Li Y, Friedman JY, O'Neal BF, et al.: Outcomes of Staphylococcus aureus infection in haemodialysis-dependent patients. Clin J Am Soc Nephrol 2009, 4: 428–34. This article highlights the clinical and economic burdens of vascular access infection. • Li Y, Friedman JY, O'Neal BF, et al.: Outcomes of Staphylococcus aureus infection in haemodialysis-dependent patients. Clin J Am Soc Nephrol 2009, 4: 428–34. This article highlights the clinical and economic burdens of vascular access infection.
4.
go back to reference Akoh JA, Riaz M. Management of patients with challenging vascular access needs. Int Surg. 2009;94:95–8.PubMed Akoh JA, Riaz M. Management of patients with challenging vascular access needs. Int Surg. 2009;94:95–8.PubMed
5.
go back to reference Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg. 2007;193:385–8.PubMedCrossRef Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg. 2007;193:385–8.PubMedCrossRef
6.
go back to reference Englesbe MJ, Al-Holou WN, Moyer AT, et al. Single centre review of femoral arteriovenous grafts for haemodialysis. World J Surg. 2006;30:171–5.PubMedCrossRef Englesbe MJ, Al-Holou WN, Moyer AT, et al. Single centre review of femoral arteriovenous grafts for haemodialysis. World J Surg. 2006;30:171–5.PubMedCrossRef
7.
go back to reference Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004;39:73–8.PubMedCrossRef Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004;39:73–8.PubMedCrossRef
8.
go back to reference Foley RN, Guo H, Snyder JJ, et al. Septicaemia in the United States dialysis population. J Am Soc Nephrol. 2004;15:1038–45.PubMedCrossRef Foley RN, Guo H, Snyder JJ, et al. Septicaemia in the United States dialysis population. J Am Soc Nephrol. 2004;15:1038–45.PubMedCrossRef
9.
go back to reference Barraclough KA, Hawley CM, Playford EG, Johnson DW. Prevention of access-related infection in dialysis. Expert Rev Anti Infect Ther. 2009;7:1185–200.PubMedCrossRef Barraclough KA, Hawley CM, Playford EG, Johnson DW. Prevention of access-related infection in dialysis. Expert Rev Anti Infect Ther. 2009;7:1185–200.PubMedCrossRef
10.
go back to reference • Millar MR, Johnson G, Wilks M, et al.: Molecular diagnosis of vascular access device-associated infection in children being treated for cancer or leukaemia. Clinic Microbiol Infect 2008, 14: 213–20. This article describes a new test able to predict likelihood of VAD survival. The study was performed by laboratory staff working at distant site who were unaware of the clinical details of individual patients. Test results are available within a few hours, providing the potential for early specific intervention for VAD infection. • Millar MR, Johnson G, Wilks M, et al.: Molecular diagnosis of vascular access device-associated infection in children being treated for cancer or leukaemia. Clinic Microbiol Infect 2008, 14: 213–20. This article describes a new test able to predict likelihood of VAD survival. The study was performed by laboratory staff working at distant site who were unaware of the clinical details of individual patients. Test results are available within a few hours, providing the potential for early specific intervention for VAD infection.
11.
go back to reference NKF-KDOQI Clinical guidelines for vascular access. Am J Kidney Dis 2006, 48: S177-S276. NKF-KDOQI Clinical guidelines for vascular access. Am J Kidney Dis 2006, 48: S177-S276.
12.
go back to reference Lafrance JP, Rahme E, Lelorier J, Iqbal S. Vascular access-related infections: definitions, incidence rates, and risk factors. Am J Kidney Dis. 2008;52:982–93.PubMedCrossRef Lafrance JP, Rahme E, Lelorier J, Iqbal S. Vascular access-related infections: definitions, incidence rates, and risk factors. Am J Kidney Dis. 2008;52:982–93.PubMedCrossRef
13.
go back to reference Ponce P, Cruz J, Ferreira A, et al. A prospective study on incidence of bacterial infections in portuguese dialysis units. Nephron. 2007;107:c133–8.PubMed Ponce P, Cruz J, Ferreira A, et al. A prospective study on incidence of bacterial infections in portuguese dialysis units. Nephron. 2007;107:c133–8.PubMed
14.
go back to reference Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA, et al.: A prospective study of haemodialysis access-related bacterial infections. J Infect Chemotherapy 2002, 8: 242–6. Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA, et al.: A prospective study of haemodialysis access-related bacterial infections. J Infect Chemotherapy 2002, 8: 242–6.
15.
go back to reference Mokrzycki MH, Zhang M, Cohen H, et al. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 2006;21:1024–31.PubMedCrossRef Mokrzycki MH, Zhang M, Cohen H, et al. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 2006;21:1024–31.PubMedCrossRef
16.
go back to reference Tokars JI, Miller ER, Stein G. New national surveillance system for haemodialysis-associated infections: initial results. Am J Infect Control. 2002;30:288–95.PubMedCrossRef Tokars JI, Miller ER, Stein G. New national surveillance system for haemodialysis-associated infections: initial results. Am J Infect Control. 2002;30:288–95.PubMedCrossRef
17.
go back to reference • Rodríguez-Aranda A, Alcazar JM, Sanz F, et al.: Endoluminal colonization as a risk factor for coagulase-negative staphylococcal catheter-related bloodstream infections in haemodialysis patients. Nephrol Dial Transplant. 2010 Aug 11. [Epub ahead of print]. This article looks at a readily available method to predict risk of catheter-related bloodstream infection. • Rodríguez-Aranda A, Alcazar JM, Sanz F, et al.: Endoluminal colonization as a risk factor for coagulase-negative staphylococcal catheter-related bloodstream infections in haemodialysis patients. Nephrol Dial Transplant. 2010 Aug 11. [Epub ahead of print]. This article looks at a readily available method to predict risk of catheter-related bloodstream infection.
18.
go back to reference Alexandraki I, Sullivan R, Zaiden R, et al. Blood culture isolates in haemodialysis vascular catheter-related bacteremia. Am J Medical Sciences. 2008;336:297–302.CrossRef Alexandraki I, Sullivan R, Zaiden R, et al. Blood culture isolates in haemodialysis vascular catheter-related bacteremia. Am J Medical Sciences. 2008;336:297–302.CrossRef
19.
go back to reference Sychev D, Maya ID, Allon M. Clinical outcomes of dialysis catheter-related candidemia in haemodialysis patients. Clin J Am Soc Nephrol. 2009;4:1102–5.PubMedCrossRef Sychev D, Maya ID, Allon M. Clinical outcomes of dialysis catheter-related candidemia in haemodialysis patients. Clin J Am Soc Nephrol. 2009;4:1102–5.PubMedCrossRef
20.
go back to reference Taylor G, Gravel D, Johnston L, et al. Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance Program. Prospective surveillance for primary bloodstream infections occurring in Canadian haemodialysis units. Infect Control Hospital Epidemiol. 2002;23:716–20.CrossRef Taylor G, Gravel D, Johnston L, et al. Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance Program. Prospective surveillance for primary bloodstream infections occurring in Canadian haemodialysis units. Infect Control Hospital Epidemiol. 2002;23:716–20.CrossRef
21.
go back to reference Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of haemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–55.PubMedCrossRef Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of haemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–55.PubMedCrossRef
23.
go back to reference Colville LA, Lee AH. Retrospective analysis of catheter-related infections in a haemodialysis unit. Infect Control Hospl Epidemiol. 2006;27:969–73.CrossRef Colville LA, Lee AH. Retrospective analysis of catheter-related infections in a haemodialysis unit. Infect Control Hospl Epidemiol. 2006;27:969–73.CrossRef
24.
go back to reference Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009;4:S5–11.PubMedCrossRef Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009;4:S5–11.PubMedCrossRef
25.
go back to reference Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol. 2009;4:456–60.PubMedCrossRef Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol. 2009;4:456–60.PubMedCrossRef
26.
go back to reference Yildizeli B, Lacin T, Batirel HF, Yuksel M. Complications and management of long-term central venous access catheters and ports. J Vasc Access. 2004;5:174–8.PubMed Yildizeli B, Lacin T, Batirel HF, Yuksel M. Complications and management of long-term central venous access catheters and ports. J Vasc Access. 2004;5:174–8.PubMed
27.
go back to reference Dendle C, Martin RD, Cameron DR, et al. Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control. Med J Aust. 2009;191:389–92.PubMed Dendle C, Martin RD, Cameron DR, et al. Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control. Med J Aust. 2009;191:389–92.PubMed
28.
go back to reference Churchill DN, Taylor DW, Cook RJ, et al. Canadian Haemodialysis morbidity study. Am J Kidney Dis. 1992;19:214–34.PubMed Churchill DN, Taylor DW, Cook RJ, et al. Canadian Haemodialysis morbidity study. Am J Kidney Dis. 1992;19:214–34.PubMed
29.
go back to reference Schild AF, Simon S, Prieto J, Raines J. Single-centre review of infections associated with 1574 consecutive vascular access procedures. Vasc Endovasc Surg. 2003;37:27–31.CrossRef Schild AF, Simon S, Prieto J, Raines J. Single-centre review of infections associated with 1574 consecutive vascular access procedures. Vasc Endovasc Surg. 2003;37:27–31.CrossRef
30.
go back to reference Akoh JA, Patel N. Infection of haemodialysis arteriovenous grafts. J Vasc Access. 2010;11:155–8.PubMed Akoh JA, Patel N. Infection of haemodialysis arteriovenous grafts. J Vasc Access. 2010;11:155–8.PubMed
31.
go back to reference Salimi J. Patency rate and complications of vascular access grafts for haemodialysis in lower extremities. Saudi J Kidney Dis Transplant. 2008;19:929–32. Salimi J. Patency rate and complications of vascular access grafts for haemodialysis in lower extremities. Saudi J Kidney Dis Transplant. 2008;19:929–32.
32.
go back to reference Antoniou GA, Lazarides MK, Georgiadis GS, et al. Lower-extremity arteriovenous access for haemodialysis: a systematic review. Eur J Vasc Endovasc Surg. 2009;38:365–72.PubMedCrossRef Antoniou GA, Lazarides MK, Georgiadis GS, et al. Lower-extremity arteriovenous access for haemodialysis: a systematic review. Eur J Vasc Endovasc Surg. 2009;38:365–72.PubMedCrossRef
33.
go back to reference Geenen IL, Nyilas L, Stephen MS, et al.: Prosthetic lower extremity haemodialysis access grafts have satisfactory patency despite a high incidence of infection. J Vasc Surg 2010 Aug 21. [Epub ahead of print] Geenen IL, Nyilas L, Stephen MS, et al.: Prosthetic lower extremity haemodialysis access grafts have satisfactory patency despite a high incidence of infection. J Vasc Surg 2010 Aug 21. [Epub ahead of print]
34.
go back to reference Abreo KD, Ram SJ. Thigh grafts: a preferable alternative to catheters when upper extremity access sites are exhausted. Semin Dial. 2009;22:469–71.PubMedCrossRef Abreo KD, Ram SJ. Thigh grafts: a preferable alternative to catheters when upper extremity access sites are exhausted. Semin Dial. 2009;22:469–71.PubMedCrossRef
35.
go back to reference Tokars JI, Light P, Anderson J, et al. A prospective study of vascular access infections at seven outpatient haemodialysis centres. Am J Kidney Dis. 2001;37:1232–40.PubMedCrossRef Tokars JI, Light P, Anderson J, et al. A prospective study of vascular access infections at seven outpatient haemodialysis centres. Am J Kidney Dis. 2001;37:1232–40.PubMedCrossRef
36.
go back to reference • Lafrance JP, Iqbal S, Lelorier J, et al.: Vascular access-related bloodstream infections in First Nations, community and teaching Canadian dialysis units, and other centre-level predictors. Nephron Clin Pract. 2010, 114: c204-12. This retrospective cohort study includes various types of dialysis centers, which makes the findings generalizable to the entire population. Center level risks of bloodstream infection are not significantly different. • Lafrance JP, Iqbal S, Lelorier J, et al.: Vascular access-related bloodstream infections in First Nations, community and teaching Canadian dialysis units, and other centre-level predictors. Nephron Clin Pract. 2010, 114: c204-12. This retrospective cohort study includes various types of dialysis centers, which makes the findings generalizable to the entire population. Center level risks of bloodstream infection are not significantly different.
37.
go back to reference • Reddy S, Sullivan R, Zaiden R, et al.: Hepatitis C infection and the risk of bacteremia in haemodialysis patients with tunneled vascular access catheters. South Med J. 2009, 102: 374–7. This article shows that HCV patients with detectable virus are at increased risk of CVC-related bacteremia. • Reddy S, Sullivan R, Zaiden R, et al.: Hepatitis C infection and the risk of bacteremia in haemodialysis patients with tunneled vascular access catheters. South Med J. 2009, 102: 374–7. This article shows that HCV patients with detectable virus are at increased risk of CVC-related bacteremia.
38.
go back to reference Salman L, Asif A. Antibiotic prophylaxis: is it needed for dialysis access procedures? Semin Dial. 2009;22:297–9.PubMedCrossRef Salman L, Asif A. Antibiotic prophylaxis: is it needed for dialysis access procedures? Semin Dial. 2009;22:297–9.PubMedCrossRef
39.
go back to reference van Loon MM, Goovaerts T, Kessels AG, et al. Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique. Nephrol Dial Transplant. 2010;25:225–30.PubMedCrossRef van Loon MM, Goovaerts T, Kessels AG, et al. Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique. Nephrol Dial Transplant. 2010;25:225–30.PubMedCrossRef
40.
go back to reference Troidle L, Eisen T, Pacelli L, Finkelstein F. Complications associated with the development of bacteraemia with Staphylococcus aureus. Haemodialysis Int. 2007;11:72–5. Troidle L, Eisen T, Pacelli L, Finkelstein F. Complications associated with the development of bacteraemia with Staphylococcus aureus. Haemodialysis Int. 2007;11:72–5.
41.
go back to reference Desai M, Rapoor R, Gudithi SL, et al. Endophthalmitis: a rare complication of arteriovenous fistula infection. Haemodialysis Int. 2008;12:227–9.CrossRef Desai M, Rapoor R, Gudithi SL, et al. Endophthalmitis: a rare complication of arteriovenous fistula infection. Haemodialysis Int. 2008;12:227–9.CrossRef
42.
go back to reference Fernandez-Cean J, Alvarez A, Burguez S, et al. Infective endocarditis in chronic haemodialysis: two treatment strategies. Nephrol Dial Transplant. 2002;17:2226–30.PubMedCrossRef Fernandez-Cean J, Alvarez A, Burguez S, et al. Infective endocarditis in chronic haemodialysis: two treatment strategies. Nephrol Dial Transplant. 2002;17:2226–30.PubMedCrossRef
43.
go back to reference •• Mermel LA, Allon M, Bouza E, et al.: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49: 1–45. These are comprehensive clinical practice guidelines for management of CVC/VAD-related infection. Analysis of data published from 2001 to 2008 was used to update the 2001 guidelines. The guidelines were written by an expert panel with widespread representation from America and Europe. •• Mermel LA, Allon M, Bouza E, et al.: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49: 1–45. These are comprehensive clinical practice guidelines for management of CVC/VAD-related infection. Analysis of data published from 2001 to 2008 was used to update the 2001 guidelines. The guidelines were written by an expert panel with widespread representation from America and Europe.
44.
go back to reference Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7:645–57.PubMedCrossRef Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7:645–57.PubMedCrossRef
45.
go back to reference Higgins M, Evans DS. Nurses' knowledge and practice of vascular access infection control in haemodialysis patients in the Republic of Ireland. J Renal Care. 2008;34:48–53.CrossRef Higgins M, Evans DS. Nurses' knowledge and practice of vascular access infection control in haemodialysis patients in the Republic of Ireland. J Renal Care. 2008;34:48–53.CrossRef
46.
go back to reference Easterlow D, Hoddinott P, Harrison S. Implementing and standardising the use of peripheral vascular access devices. J Clinic Nursing. 2010;19:721–7.CrossRef Easterlow D, Hoddinott P, Harrison S. Implementing and standardising the use of peripheral vascular access devices. J Clinic Nursing. 2010;19:721–7.CrossRef
47.
go back to reference Patel PR, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of bloodstream infections in haemodialysis patients. Am J Kidney Dis. 2010;56:566–77.PubMedCrossRef Patel PR, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of bloodstream infections in haemodialysis patients. Am J Kidney Dis. 2010;56:566–77.PubMedCrossRef
48.
go back to reference • Rabindranath KS, Bansal T, Adams J, et al.: Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant. 2009; 24: 3763–74. This article is a systematic review of 29 trials involving 3005 catheters in 2886 patients showing antimicrobial locks and exit site antimicrobials reduce CVC infections. • Rabindranath KS, Bansal T, Adams J, et al.: Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant. 2009; 24: 3763–74. This article is a systematic review of 29 trials involving 3005 catheters in 2886 patients showing antimicrobial locks and exit site antimicrobials reduce CVC infections.
49.
go back to reference Tercier S, Gapany C, Diezi M, et al. Incidents and complications of totally implanted vascular access devices in children: a prospective study. Patient Saf Surg. 2008;2:30.PubMedCrossRef Tercier S, Gapany C, Diezi M, et al. Incidents and complications of totally implanted vascular access devices in children: a prospective study. Patient Saf Surg. 2008;2:30.PubMedCrossRef
50.
go back to reference • Katzman HE, McLafferty RB, Ross JR, et al.: Initial experience and outcome of a new haemodialysis access device for catheter-dependent patients. J Vasc Surg 2009; 50: 600–7, 607.e1. This article describes a new device for ensuring access in patients with central venous obstruction. • Katzman HE, McLafferty RB, Ross JR, et al.: Initial experience and outcome of a new haemodialysis access device for catheter-dependent patients. J Vasc Surg 2009; 50: 600–7, 607.e1. This article describes a new device for ensuring access in patients with central venous obstruction.
Metadata
Title
Vascular Access Infections: Epidemiology, Diagnosis, and Management
Author
Jacob A. Akoh
Publication date
01-08-2011
Publisher
Current Science Inc.
Published in
Current Infectious Disease Reports / Issue 4/2011
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-011-0192-x

Other articles of this Issue 4/2011

Current Infectious Disease Reports 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.